Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

News

 

CBPE Capital buys rapidly expanding UK varicose vein treatment chain

Dermatology is hot right now. UK private equity firm Palatine has sold its stake in Veincentre, the UK’s largest chain varicose vein treatment provider, to CBPE Capital (another UK private equity group). This follows the acquisition of Dutch dermatology group Mauritskliniek last month.

FutureLife enters Spain and Italy

FutureLife, the Czech Republic-based fertility company, has entered Spain and Italy with its latest acquisition. Owned by PE companies CVC and Hartenberg holding, the group has acquired Institut Marquès (IM), an assisted reproduction company based in Barcelona with clinics in Spain and Italy.

M&A health care deals slow on debt fears

After a heady 2021, activity in European health care M&A is slowing down. Big ticket auctions have been withdrawn and processes are often run more cautiously as dual track, rather than general auctions. But underlying demand for health care assets is strong, with PE sitting on trillions of recently raised dry powder. Listed groups look cheap. HBI catches up with bankers from across Europe for their take.

Henry Dunant-Euromedica merger unlikely to sell for three years

The company formed as a result of the merger between Euromedica and Imithea, the parent company of Henry Dunant, Greece’s largest private hospital, is unlikely to sell for three years, HBI hears. Click here to read our reports on the for-profit hospital sector, and here to read more about Euromedica, and here to read more […]

CVC to buy back Quironsalud?

Rumours circulate that Quironsalud, the Spanish hospital subsidiary of hospital chain Fresenius Helios, may be sold to private equity firm CVC or KKR, HBI hears. But others say the new CEO of Helios' parent, Fresenius SE, is unlikely to go for the strategy and suggest the dialysis arm could be put on the block instead.

French labs pushing back against €250m cut

French labs are presenting a united front pushing back against the €250m worth of annual cuts proposed in the 2023 Social Security Budget. All of the sector’s representative bodies have voiced outrage, and a joint letter from the directors of four labs syndicates sent to l’Assurance Maladie’s (CNAM) general director demands tariffs be indexed to inflation saying the sector cannot support further cuts. 

Opportunities in Irish dentistry

The dental market in Ireland may not be the largest in Europe, but it is largely (80% plus) a private market with very little consolidation. So why haven't we seen more consolidation? HBI speaks to a market expert to find out more.

Germany to reduce inpatients by a quarter, as hospitals face insolvency

German health minister Karl Lauterbach is to implement the country's first major health care reform in 20 years. From 2023, hospitals will aim to reduce spiralling costs and remedy the workforce crisis by shifting as much as 25% of their inpatient activity to outpatient and, eventually, closing some clinics and hospitals. HBI chats to German sources to find out more about what this means for for-profit operators.

Find Us